# Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

> **NCT01159288** · PHASE2 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 41 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Dex2

## Key facts

- **NCT ID:** NCT01159288
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-19
- **Primary completion:** 2015-12-19
- **Final completion:** 2015-12-19
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159288, "Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01159288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*